ANRO
Alto Neuroscience, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Alto Neuroscience, Inc.
22.40
−1.07 · −4.56%
post 22.40 −0.01%
No thesis.
Expected move
Inputsstraddle ±16.7%
spot 22.60exp Nov 20ATM strike 22.5ATM straddle 4.45IV 103%
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Falcon Edge CapitalFalcon Edge Capital | $97.8M | 12.54% | 0.00% | |
| 2 | Commodore CapitalCommodore Capital | $71.9M | 9.21% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $56.0M | 7.17% | +218.38% | |
| 4 | Perceptive AdvisorsPerceptive | $42.5M | 5.44% | −19.90% | |
| 5 | Adage Capital Partners GPAdage Capital Partners GP | $42.2M | 5.41% | +315.58% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $36.7M | 4.70% | +15.12% | |
| 7 | Spruce Street CapitalSpruce Street Capital | $35.7M | 4.58% | +2.10% | |
| 8 | Vivo CapitalVivo Capital | $31.9M | 4.09% | +16.74% | |
| 9 | Franklin ResourcesFranklin Resources | $26.7M | 3.43% | −8.04% | |
| 10 | Armistice CapitalArmistice Capital | $22.8M | 2.92% | −5.26% | |
| 11 | Affinity Asset AdvisorsAffinity Asset | $22.4M | 2.87% | +70.00% | |
| 12 | Vestal Point CapitalVestal Point Capital | $20.7M | 2.65% | −61.97% | |
| 13 | State StreetState Streetindex-like | $18.1M | 2.32% | +243.83% | |
| 14 | Geode Capital ManagementGeodeindex-like | $17.9M | 2.29% | +131.55% | |
| 15 | 72 Investment Holdings72 Investment | $17.6M | 2.26% | 0.00% | |
| 16 | Northern TrustNorthern Trustindex-like | $16.7M | 2.14% | +33.65% | |
| 17 | Millennium ManagementMillennium | $14.7M | 1.89% | −32.08% | |
| 18 | Point72 Asset ManagementPoint72 | $13.3M | 1.70% | −0.03% | |
| 19 | VR AdviserVR Adviser | $13.2M | 1.69% | 0.00% | |
| 20 | Integral Health Asset ManagementIntegral Health | $13.2M | 1.69% | 0.00% | |
| 21 | Driehaus Capital ManagementDriehaus | $12.9M | 1.65% | +0.17% | |
| 22 | Parkman Healthcare PartnersParkman Healthcare Partners | $11.3M | 1.45% | new | |
| 23 | Ikarian CapitalIkarian Capital | $10.7M | 1.38% | −20.91% | |
| 24 | T. Rowe Price AssociatesT. Rowe Price | $9.5M | 1.21% | −3.48% | |
| 25 | Orbimed AdvisorsOrbimed | $6.8M | 0.87% | +53.94% |
116 managers report $780.4M of Alto Neuroscience on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; Falcon Edge Capital is largest at 12.54%.